跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
HSA
/
FLUARIX SUSPENSION FOR INJECTION
Approved
THERAPEUTIC
FLUARIX SUSPENSION FOR INJECTION
GlaxoSmithKline Biologicals, Branch of SmithKline Beecham Pharma GmbH & Co. KG (GERMANY)
🇸🇬 Health Sciences Authority
Approval Date
Feb 13, 2026
Approval ID
782157938f6799d0
Company
GlaxoSmithKline Biologicals, Branch of SmithKline Beecham Pharma GmbH & Co. KG (GERMANY)
Type
Therapeutic
Approval Details
Approval Id
782157938f6799d0
Drug Name
FLUARIX SUSPENSION FOR INJECTION
Product Name
FLUARIX SUSPENSION FOR INJECTION
Approval Number
SIN17468P
Approval Date
2026-02-13
Registrant
GLAXOSMITHKLINE PTE LTD
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
INJECTION, SUSPENSION
Route Of Administration
INTRAMUSCULAR
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Feb 13, 2026
Approval ID
782157938f6799d0
Type
Therapeutic
Back to HSA Approvals
FLUARIX SUSPENSION FOR INJECTION - HSA Drug Approval Details